Acute Myeloid Leukemia
FAB and WHO classification of acute myeloid leukemia discussed
Published in Blood Weekly, February 2nd, 2006
According to recent research from Germany, "In routine diagnostic procedures of AML, the FAB and WHO classifications both play a central role. Some morphologic subtypes are specifically associated to distinct cytogenetic and molecular aberrations; however, such close correlations do not exist for the majority of entities."
"We evaluated cytogenetics in 2,235 patients at diagnosis of AML with the FAB subtypes M0-2, M4, and M5-7. The cytogenetic patterns of these subtypes showed differences with respect to the clonal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-02-02)
More Articles from Blood Weekly
- Blood Safety
Methylene blue photoinactivation abolishes West Nile virus infectivity in blood products - Cord Blood
Thawing and washing results in a substantial loss of umbilical cord blood cells - Stem Cell Research
Targeting cancer stem cells may inhibit tumor progression and disease recurrence - Stem Cell Transplantation
Older peripheral blood stem cells donors may be poorer mobilizers than younger donors - Tissue Engineering
Blended nanofibrous scaffold promotes faster tissue regeneration - Acute Renal Failure
Compared with systemic heparin, regional citrate anticoagulation improves filter lifespan in CCRT - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
